@nhtheraguix.com
Nanomedicine technology is an innovative therapeutic approach that has the potential to improve conventional radiotherapy treatment.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
NH TherAguix is a leading brand in the field of cancer treatment, offering innovative solutions to improve the effectiveness of radiotherapy. With a focus on developing the AGuIX® drug, NH TherAguix aims to enhance the treatment of various cancer indications, including pancreas, lung, head and neck, glioblastoma, and brain metastasis. Founded in 2015 by scientists Géraldine Le Duc and Pr Olivier Tillement, NH TherAguix is a French biotechnology company based in Grenoble.
Their groundbreaking theranostic nanodrug, AGuIX®, is designed to fight cancer more efficiently. Thanks to a successful €13M fund raising in 2019, NH TherAguix has been able to launch a promising portfolio of clinical trials. Partnering with various organizations, NH TherAguix is at the cutting-edge of cancer treatment, striving to improve the lives of patients worldwide.
With their commitment to research and development, NH TherAguix is dedicated to transforming the landscape of cancer care. For more information, visit their website or contact them directly
Company Type
Privately Held
Company Size
11-50
Year Founded
2015
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online